ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,069Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 1206

$772K Total Retail Price of All Prescriptions

Rank: 28 out of 1206

453 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 453 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

20% of this provider’s 453 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 11,082 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
AMLODIPINE BESYLATE 664 513 1 6
OMEPRAZOLE 642 472 2 3
LEVOTHYROXINE SODIUM 637 505 3 2
FUROSEMIDE 615 513 4 5
SIMVASTATIN 484 372 5 1
TRAMADOL HCL 401 236 6 17
HYDROCODONE-ACETAMINOPHEN 359 186 S3 7 7
POLYETHYLENE GLYCOL 3350 355 308 8 31
LISINOPRIL 339 248 9 4
POTASSIUM CHLORIDE 311 256 10 12
METFORMIN HCL ER 298 215 11 58
WARFARIN SODIUM 289 232 12 8
METOPROLOL SUCCINATE 285 224 13 15
KLOR-CON 10 267 218 14 93
GLIMEPIRIDE 204 129 15 34
IPRATROPIUM-ALBUTEROL 198 194 16 139
CITALOPRAM HBR 193 132 17 16
METOPROLOL TARTRATE 190 136 18 9
FLUOXETINE HCL 187 154 19 52
RISPERIDONE 167 134 20 74
CRESTOR 167 62 20 30
METFORMIN HCL 158 58 22 10
DONEPEZIL HCL 151 138 23 29
GABAPENTIN 148 85 24 18
LEVOFLOXACIN 147 118 25 78
PANTOPRAZOLE SODIUM 136 104 26 54
ATENOLOL 135 93 27 14
TAMSULOSIN HCL 129 109 28 26
ATORVASTATIN CALCIUM 128 69 29 13
SERTRALINE HCL 124 87 30 22
AMITRIPTYLINE HCL 116 62 R 31 59
ZOLPIDEM TARTRATE 111 67 32 25
QUETIAPINE FUMARATE 108 101 33 79
SEROQUEL 107 97 34 164
OXYCODONE-ACETAMINOPHEN 105 58 S2 35 106
TRAZODONE HCL 104 54 36 37
CYCLOBENZAPRINE HCL 100 15 R 37 80
MUPIROCIN 99 33 38 185
HYDROCHLOROTHIAZIDE 97 73 39 11
RANITIDINE HCL 97 69 39 23
NAMENDA 96 69 41 36
ISOSORBIDE MONONITRATE ER 93 88 42 40
MIRTAZAPINE 90 74 43 50
LANTUS 89 47 44 38
CLOTRIMAZOLE-BETAMETHASONE 86 45 45 184
TRICOR 85 44 46 130
LYRICA 84 28 47 115
LEVETIRACETAM 83 42 48 135
GLIPIZIDE 82 53 49 64
METOCLOPRAMIDE HCL 76 58 50 127
FLUTICASONE PROPIONATE 75 50 51 42
AZITHROMYCIN 75 60 51 46
VENLAFAXINE HCL ER 74 0 53 89
ALENDRONATE SODIUM 70 66 54 19
ADVAIR DISKUS 69 36 55 55
CLOPIDOGREL 69 51 55 48
CEPHALEXIN 67 53 57 62
PAROXETINE HCL 66 65 58 53
IBUPROFEN 65 0 59 116
ESCITALOPRAM OXALATE 64 44 60 86
OXYBUTYNIN CHLORIDE 62 41 61 68
PROPRANOLOL HCL 62 36 61 92
COMBIVENT 62 42 61 150
NABUMETONE 62 39 61 91
PHENYTOIN SODIUM EXTENDED 61 37 65 138
PRAVASTATIN SODIUM 58 57 66 21
PREDNISONE 58 45 66 28
MELOXICAM 57 51 68 35
ALLOPURINOL 56 46 69 24
CARVEDILOL 56 54 69 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 56 36 69 27
CYMBALTA 55 30 72 63
LAMOTRIGINE 55 22 72 162
PROAIR HFA 54 20 74 49
LIPITOR 54 29 74 113
AMLODIPINE BESYLATE-BENAZEPRIL 53 39 76 76
LANTUS SOLOSTAR 53 25 76 85
BUPROPION HCL SR 53 29 76 171
CARBIDOPA-LEVODOPA 51 51 79 70
ENALAPRIL MALEATE 51 49 79 45
BENAZEPRIL HCL 50 41 81 39
DIVALPROEX SODIUM ER 50 32 81 163
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 1, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.